| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 5.79 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide. Early detection of this neoplasia has proven to improve prognosis, resulting in a 90% increase in survival. However, available CRC screening methods have limitations, requiring the development of new tools. MicroRNA biomarkers have emerged as a powerful screening tool, as they are highly expressed in CRC patients and easily detectable in several biological samples. While microRNAs are extensively studied in blood samples, recent interest has now arisen in other samples, such as stool samples, where they can be combined with existing screening methods. Among the microRNAs described in the literature, microRNA-21-5p and microRNA-92a-3p and their cluster have demonstrated high potential for early CRC screening. Furthermore, the combination of multiple microRNAs has shown improved performance in CRC detection compared to individual microRNAs. This review aims to assess the available data in the literature on microRNAs as promising biomarkers for early CRC screening, explore their advantages and disadvantages, and discuss the optimal study characteristics for analyzing these biomarkers.
Description
Keywords
MicroRNA Colorectal cancer Biomarker Screening Early detection
Citation
Santos, D. A. R., Gaiteiro, C., Santos, M., Santos, L., Dinis-Ribeiro, M., & Lima, L. (2023). MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening—A Comprehensive Review. International Journal of Molecular Sciences, 24(13), 11023. https://doi.org/10.3390/ijms241311023
Publisher
MDPI